查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1628060

左心耳封堵器市场机会、成长驱动因素、产业趋势分析与预测 2024 - 2032 年

Left Atrial Appendage Closure Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 131 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球左心耳封堵器械市场价值为18 亿美元，预计将经历显着增长，2024 年至2032 年复合年增长率预计为19.2%。 、医疗技术的不断进步是推动这一市场扩张的关键驱动力。

市场主要分为两类产品：心内膜左心耳装置及心外膜左心耳装置。其中，心内膜左心耳装置占据最大份额，2023年产值达16亿美元。这些装置因其能够减少血栓栓塞事件的发生，同时保持良好的手术併发症风险状况而广受认可。此外，心内膜左心耳封堵装置被视为与心房颤动消融手术结合的可靠选择。

就最终用户而言，市场分为医院、门诊手术中心和其他医疗机构。医院细分市场将在 2023 年占据主导地位，预计到预测期结束时将达到 60 亿美元。由于越来越多地使用具有卓越可操作性的先进左心耳闭合装置，医院继续引领市场，这可能会提高患者对这些设定的偏好。需要治疗心房颤动的患者数量不断增加，加上疾病筛检工作的增加和医疗基础设施的改善，进一步支持了这个细分市场的扩张。随着医疗保健系统的改善，心房颤动在已开发市场和新兴市场的流行也有望推动医院市场的成长。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 18亿美元
预测值 88亿美元
复合年增长率 19.2%

北美左心耳封堵器市场 2023 年营收为 13 亿美元，预计 2024 年至 2032 年复合年增长率为 17.6%。主要产业参与者继续推动新设备的开发和商业化创新，进一步加强市场的扩张。心房颤动盛行率的不断上升以及随后住院人数的增加将继续推动该地区对左心耳封堵器的需求。

在技​​术创新、疾病盛行率上升以及各种医疗保健环境中越来越多地采用这些设备的推动下，左心耳封堵设备市场将实现强劲成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 心房颤动的盛行率不断增加
      • 强大的产品管线
      • 增加政府倡议
      • 左心耳封堵器的技术进步
    • 产业陷阱与挑战
      • 替代技术的存在
      • LAA 封堵器成本高
  • 成长潜力分析
  • 监管环境
  • 报销场景
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

  • 主要趋势
  • 心内膜左心耳装置
  • 心外膜左心耳装置

第 6 章：市场估计与预测：按程序，2021 - 2032

  • 主要趋势
  • 经皮
  • 外科

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 9 章：公司简介

  • Abbott Laboratories
  • AtriCure
  • Boston Scientific Corporation
  • Lepu Medical Technology
  • LifeTech Scientific
  • MicroPort Scientific Corporation
  • Nanjing YDB Technology
  • Shanghai Push Medical Device Technology
简介目录
Product Code: 3960

The Global Left Atrial Appendage Closure Devices Market was valued at USD 1.8 billion in 2023 and is projected to experience significant growth, with an estimated CAGR of 19.2% from 2024 to 2032. The rising incidence of atrial fibrillation (AF), supportive government policies, and continuous advancements in medical technology are key drivers contributing to this market expansion.

The market is primarily divided into two product categories: endocardial LAA devices and epicardial LAA devices. Among these, endocardial LAA devices accounted for the largest share, generating USD 1.6 billion in 2023. The growth in this segment is attributed to the increasing demand for devices that effectively minimize the risk of blood clots from the left atrial appendage entering the bloodstream. These devices are widely recognized for their ability to reduce the occurrence of thromboembolic events while maintaining a favorable risk profile for procedural complications. Additionally, endocardial LAA closure devices are seen as a reliable option in combination with atrial fibrillation ablation procedures.

In terms of end users, the market is segmented into hospitals, ambulatory surgical centers, and other healthcare facilities. The hospital segment dominated in 2023 and is expected to reach USD 6 billion by the end of the forecast period. Hospitals continue to lead the market due to the increasing use of advanced LAA closure devices that offer superior operability, which is likely to boost patient preference for these settings. The growing number of patients requiring treatment for AF, coupled with a rise in disease screening efforts and improved healthcare infrastructure, further supports the expansion of this segment. The prevalence of AF in both developed and emerging markets with improving healthcare systems is also expected to drive hospital-based market growth.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$1.8 Billion
Forecast Value$8.8 Billion
CAGR19.2%

North America market for LAA closure devices generated USD 1.3 billion in revenue in 2023 and is projected to grow at a CAGR of 17.6% from 2024 to 2032. Factors such as the presence of leading manufacturers, rising demand for LAA closure products, and the growing number of AF cases are pivotal to this market's robust growth. Key industry players continue to drive innovation in the development and commercialization of new devices, further reinforcing the market's expansion. The increasing prevalence of atrial fibrillation and the subsequent rise in hospital admissions will continue to fuel the demand for LAA closure devices in the region.

The left atrial appendage closure device market is positioned for strong growth, driven by technological innovations, rising disease prevalence, and increasing adoption of these devices in various healthcare settings.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of atrial fibrillation
      • 3.2.1.2 Strong product pipeline
      • 3.2.1.3 Increasing government initiatives
      • 3.2.1.4 Technological advancements in left atrial appendage closure devices
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Presence of alternate technologies
      • 3.2.2.2 High cost of LAA closure devices
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Reimbursement scenario
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn & Units)

  • 5.1 Key trends
  • 5.2 Endocardial LAA devices
  • 5.3 Epicardial LAA devices

Chapter 6 Market Estimates and Forecast, By Procedure, 2021 - 2032 ($ Mn & Units)

  • 6.1 Key trends
  • 6.2 Percutaneous
  • 6.3 Surgical

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn and Units)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn and Units)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 AtriCure
  • 9.3 Boston Scientific Corporation
  • 9.4 Lepu Medical Technology
  • 9.5 LifeTech Scientific
  • 9.6 MicroPort Scientific Corporation
  • 9.7 Nanjing YDB Technology
  • 9.8 Shanghai Push Medical Device Technology